Empagliflozin Not Tied to Risk for New Nonproliferative Diabetic Retinopathy
Empagliflozin may lower risk for diabetic retinopathy progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Empagliflozin may lower risk for diabetic retinopathy progression
Only registered members have full access to PracticeUpdate content.